Sydney K. Davis, PharmD

Articles by Sydney K. Davis, PharmD

Intensive care unit (ICU) -- Image credit: sudok1 | stock.adobe.com

The Impact of Pharmacist-Managed Insulin Therapy in the Intensive Care Unit

BySydney K. Davis, PharmD,Michael A. Maccia, PharmD, BCCCP,Kinsey M. Johannemann, PharmD, BCPS,Eden E. Brewington, PharmD, BCCCP,Daniel C. Smith, MD

July 21st 2025

Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.

Sydney K. Davis, PharmD

Articles by Sydney K. Davis, PharmD

The Impact of Pharmacist-Managed Insulin Therapy in the Intensive Care Unit

Latest Updated Articles

Trending on Pharmacy Times

Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer

Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer

Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer

Expert Discusses Early Safety and Tolerability Findings for VMT-α-NET in Neuroendocrine Tumors | ESMO 2025

TAR-200 Intravesical System Demonstrates Sustained Bladder Exposure in BCG-Unresponsive NMIBC